SLI

SLI handeln
2.212,64 PKT -3,09 PKT -0,14 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0QZBF

ISIN CH0030252883


Analysen zu SLI-Werten

Datum Rating Analyst
11.02.05 Nestlé Neutral Sarasin Research
10.02.05 Zurich Insurance Buy Merrill Lynch
10.02.05 UBS Buy Sarasin Research
11.02.05 Swiss Life Akkumulieren Nord LB
10.02.05 Swiss Life Marketperformer LB Rheinland-Pfalz
10.02.05 Swiss Life Outperform HypoVereinsbank
10.02.05 Swiss Life Outperform HypoVereinsbank
10.02.05 Swiss Life Buy M.M. Warburg
09.02.05 Logitech Neutral Sarasin Research
09.02.05 Novartis Buy Merrill Lynch
09.02.05 Swiss Life Buy Merck Finck & Co
09.02.05 Roche Buy Merrill Lynch
10.02.05 Zurich Insurance Halten Helaba Trust
11.02.05 UBS Outperformer Sparkasse KölnBonn
09.02.05 SGS SA Market Perform Vontobel
09.02.05 UBS Buy Sarasin Research
09.02.05 UBS Overweight JP Morgan
09.02.05 UBS Outperform Goldman Sachs
08.02.05 ABB (Asea Brown Boveri) Neutral JP Morgan
09.02.05 Richemont Buy Sarasin Research
09.02.05 UBS Verkaufen Helaba Trust
08.02.05 UBS Akkumulieren Independent Research
08.02.05 UBS Outperform Credit Suisse First Boston
09.02.05 UBS Overweight Lehman Brothers
08.02.05 Zurich Insurance Buy Sarasin Research
07.02.05 ABB (Asea Brown Boveri) Kaufen Helaba Trust
08.02.05 UBS Overweight JP Morgan
07.02.05 UBS Overweight JP Morgan
07.02.05 Roche Buy Sarasin Research
07.02.05 Swiss Life Marketperformer LB Rheinland-Pfalz
07.02.05 ABB (Asea Brown Boveri) Neutral Sarasin Research
07.02.05 UBS Halten Helaba Trust
03.03.05 Givaudan Neutral Sarasin Research
03.02.05 Helvetia Baloise Buy Sarasin Research
03.02.05 ABB (Asea Brown Boveri) Halten Helaba Trust
07.02.05 UBS Buy SEB
03.02.05 Zurich Insurance Neutral JP Morgan
03.02.05 Roche In-Line Goldman Sachs
03.02.05 Swiss Life Outperform HypoVereinsbank
03.02.05 Roche Buy Sarasin Research